A detailed history of York Bridge Wealth Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, York Bridge Wealth Partners, LLC holds 16,416 shares of ABBV stock, worth $2.95 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
16,416
Previous 16,819 2.4%
Holding current value
$2.95 Million
Previous $2.26 Million 17.59%
% of portfolio
0.67%
Previous 0.58%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023

SELL
$138.31 - $165.87 $55,738 - $66,845
-403 Reduced 2.4%
16,416 $0
Q3 2022

Oct 18, 2022

BUY
$134.21 - $153.93 $64,152 - $73,578
478 Added 2.93%
16,819 $2.26 Million
Q2 2022

Jul 15, 2022

BUY
$137.62 - $174.96 $412 - $524
3 Added 0.02%
16,341 $2.5 Million
Q1 2022

Apr 15, 2022

SELL
$131.98 - $163.75 $1,187 - $1,473
-9 Reduced 0.06%
16,338 $2.65 Million
Q4 2021

Jan 19, 2022

SELL
$107.43 - $135.93 $10,743 - $13,593
-100 Reduced 0.61%
16,347 $2.21 Million
Q1 2021

Apr 15, 2021

BUY
$102.3 - $112.62 $1.18 Million - $1.3 Million
11,500 Added 232.46%
16,447 $1.78 Million
Q4 2020

Jan 19, 2021

SELL
$80.49 - $108.67 $2,253 - $3,042
-28 Reduced 0.56%
4,947 $530,000
Q2 2020

Jul 20, 2020

BUY
$73.37 - $98.18 $12,839 - $17,181
175 Added 3.65%
4,975 $488,000
Q4 2019

Jan 17, 2020

BUY
$72.13 - $90.25 $21,278 - $26,623
295 Added 6.55%
4,800 $425,000
Q3 2019

Oct 21, 2019

SELL
$62.98 - $75.72 $12,218 - $14,689
-194 Reduced 4.13%
4,505 $341,000
Q1 2019

May 09, 2019

SELL
$77.14 - $90.79 $28,233 - $33,229
-366 Reduced 7.23%
4,699 $379,000
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $13,692 - $15,221
-154 Reduced 2.95%
5,065 $481,000
Q4 2017

Feb 12, 2018

SELL
$89.56 - $98.21 $55,079 - $60,399
-615 Reduced 10.54%
5,219 $572,000
Q3 2017

Oct 27, 2017

SELL
$69.85 - $89.22 $2,374 - $3,033
-34 Reduced 0.58%
5,834 $518,000
Q2 2017

Aug 14, 2017

BUY
N/A
5,868
5,868 $425,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track York Bridge Wealth Partners, LLC Portfolio

Follow York Bridge Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of York Bridge Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on York Bridge Wealth Partners, LLC with notifications on news.